Hepatotoxicity associated with etanercept in psoriatic arthritis

Journal of Rheumatology

Volumn 35, Issue 11, 2008, Pages 2286-2288

  Leak, Alison M ^a   Rincon Aznar, Blanca ^a  

^a EAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; ETANERCEPT;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LETTER; LIVER FUNCTION TEST; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; TOXIC HEPATITIS;

ARTHRITIS, PSORIATIC; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; LIVER DISEASES; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 56449101764     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.080521     Document Type: Letter

References (7)

1. Farah M, Al Rashidi A, Owen DA, Yoshida EM, Reid GD. Granulomatous hepatitis associated with etanercept therapy. J Rheumatol 2008;35:349-51.
2. Antoni C, Krueger GG, de Vlam K, et al. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 Trial. Ann Rheum Dis 2005;64:1150-7.
3. Feletar M, Brockbank JE, Schentag CT, Lapp V, Gladman DD. Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients. Ann Rheum Dis 2004;63:156-61.
4. Braun J, Brant J, Listing J, et al. Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis. An open, observational, extension study of a three-month, randomized placebo-controlled trial. Arthritis Rheum 2003;48:2224-33.
5. Van der Heijde D, Dijkmans B, Geusens P, et al. Efficacy and safety of infliximab in patients with ankylosing spondylitis. Results of a randomized, placebo-controlled trial (ASSERT). Arthritis Rheum 2005;52:582-91.
6. NICE Technology Appraisal Guidance 104: Etanercept and infliximab for the treatment of adults with psoriatic arthritis. London: National Institute for Health and Clinical Excellence; July 2006.
7. Mease PJ, Kivitz AJ, Burch FX, et al. Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept. J Rheumatol 2006;33:712-21.